CoChat

Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells

Open access
Condorelli, F, Gnemmi, I, Vallario, A, Genazzani, A A, Canonico, P L · 2008 · British Journal of Pharmacology
Cited by 121

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background and purpose: Inhibitors of histone deacetylase (HDAC) are emerging as a promising class of anti‐cancer drugs, but a generic deregulation of transcription in neoplastic cells cannot fully explain their therapeutic effects. In this study we evaluated alternative molecular mechanisms by which HDAC inhibitors could affect neuroblastoma viability. Experimental approach: Effects of HDAC inhibitors on survival of the I‐type SK‐N‐BE and the N‐type NB SH‐SY5Y neuroblastoma cell lines were assessed by the MTT assay. Molecular pathways leading to this were examined by western blot, confocal microscopy and cytofluorometry. The mRNA levels of apoptotic mediators were assessed semi‐quantitatively by RT‐PCR. Tumour‐suppressor p53 trans activity was assessed in EMSA experiments. HDAC inhibitors were also studied in cells subjected to plasmid‐based p53 interference (p53i). Key results: HDAC inhibitors induced cell death via the mitochondrial pathway of apoptosis with recruitment of Bcl‐2 family members. Bcl‐2 overexpression rendered neuroblastoma cells resistant to HDAC inhibitor treatment. Low concentrations of HDAC inhibitors (0.9 m M) caused a G 2 cell‐cycle arrest and a marked upregulation of the p21/Waf1/Cip1 protein. HDAC inhibitors also activate the p53 protein via hyper‐acetylation and nuclear re‐localization, without affecting its protein expression. Accordingly, HDAC inhibitor‐induced cell‐killing and p21/Waf1/Cip1 upregulation is impaired in p53i‐cells. Conclusions and implications: In neuroblastoma cells, HDAC inhibitors may overcome the resistance to classical chemotherapeutic drugs by restoring the p53 tumour‐repressor function via its hyper‐acetylation and nuclear migration, events usually impaired in such tumours. In neuroblastoma cells, HDAC inhibitors are not able to induce p21/Waf1/Cip1 in the absence of a functional p53. British Journal of Pharmacology (2008) 153, 657–668; doi:10.1038/sj.bjp.0707608; published online 3 December 2007

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0707608

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 121

Metadata

Authors
Condorelli, F., Gnemmi, I., Vallario, A., Genazzani, A. A., & Canonico, P. L.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2008-02
Volume
153
Issue
4
Pages
657-668
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2164360261
Cited by
121
References
5
FWCI
2.27
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells. https://app.cochat.ai/papers/10.1038/sj.bjp.0707608
The paper
Condorelli, F., Gnemmi, I., Vallario, A., Genazzani, A. A., & Canonico, P. L. (2008). Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707608

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.